{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:13Z","timestamp":1786993693149,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lungcan.2024.107897","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T15:12:09Z","timestamp":1721833929000},"page":"107897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1446-6442","authenticated-orcid":false,"given":"Qian","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-3294","authenticated-orcid":false,"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3927-6218","authenticated-orcid":false,"given":"Weiya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lungcan.2024.107897_b0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","article-title":"MET-dependent solid tumours \u2013 molecular diagnosis and targeted therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2011.06.004","article-title":"Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients","volume":"75","author":"Tanaka","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtho.2016.10.014","article-title":"Targeting MET in lung cancer: will expectations finally be MET?","volume":"12","author":"Drilon","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107897_b0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107897_b0025","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","article-title":"Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107897_b0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/cancers15030612","article-title":"MET amplification as a resistance driver to TKI therapies in lung cancer: clinical challenges and opportunities","volume":"15","author":"Qin","year":"2023","journal-title":"Cancers"},{"issue":"suppl_1","key":"10.1016\/j.lungcan.2024.107897_b0035","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107897_b0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40265-021-01477-2","article-title":"Targeted therapy approaches for MET abnormalities in non-small cell lung cancer","volume":"81","author":"Garon","year":"2021","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107897_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100451","article-title":"Unraveling the significance of MET focal amplification in lung cancer: integrative NGS, FISH, and IHC investigation","volume":"37","author":"Xiang","year":"2024","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107897_b0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/2767-9764.CRC-22-0438","article-title":"Detection of MET polysomy by next-generation sequencing and its clinical relevance for MET inhibitors","volume":"3","author":"Sun","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.lungcan.2024.107897_b0055","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.csbj.2019.09.003","article-title":"Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors","volume":"17","author":"Heydt","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"19","key":"10.1016\/j.lungcan.2024.107897_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13195023","article-title":"MET amplification in non-small cell lung cancer (NSCLC) \u2013 a consecutive evaluation using next-generation sequencing (NGS) in a real-world setting","volume":"13","author":"Schubart","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/2159-8290.CD-22-0586","article-title":"Osimertinib + savolitinib to overcome acquired MET-mediated resistance in epidermal growth factor receptor-mutated, MET-amplified non-small cell lung cancer: TATTON","volume":"13","author":"Hartmaier","year":"2023","journal-title":"Cancer Discov."},{"issue":"16","key":"10.1016\/j.lungcan.2024.107897_b0070","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucl. Acids Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-021-01371-1","article-title":"Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer","volume":"20","author":"Nagasaka","year":"2021","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.lungcan.2024.107897_b0080","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/1078-0432.CCR-19-0624","article-title":"Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer","volume":"25","author":"Leighl","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.lungcan.2024.107897_b0085","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/cncr.33571","article-title":"High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: the Korean Lung Liquid Versus Invasive Biopsy Program","volume":"127","author":"Park","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107897_b0090","first-page":"1094","article-title":"Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer","volume":"51","author":"Chinese Society of","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107897_b0095","doi-asserted-by":"crossref","first-page":"e12375","DOI":"10.1002\/2056-4538.12375","article-title":"Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis","volume":"10","author":"Sun","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"issue":"5827","key":"10.1016\/j.lungcan.2024.107897_b0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107897_b0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10637-020-01010-4","article-title":"A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer","volume":"39","author":"Yang","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.lungcan.2024.107897_b0110","first-page":"1","article-title":"Phase I\/II study of capmatinib plus erlotinib in patients with MET-positive non-small-cell lung cancer","author":"McCoach","year":"2021","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107897_b0115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.22.00739","article-title":"Phase Ib study of telisotuzumab vedotin in combination with erlotinib in patients with c-met protein-expressing non-small-cell lung cancer","volume":"41","author":"Camidge","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2024.107897_b0120","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/1078-0432.CCR-15-2061","article-title":"MET amplification and exon 14 splice site mutation define unique molecular subgroups of non-small cell lung carcinoma with poor prognosis","volume":"22","author":"Tong","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107897_b0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00432-022-04048-4","article-title":"Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer","volume":"149","author":"Fan","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2024.107897_b0130","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/bioinformatics\/bty043","article-title":"Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants","volume":"34","author":"Luo","year":"2018","journal-title":"Bioinformatics"},{"issue":"21","key":"10.1016\/j.lungcan.2024.107897_b0135","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1158\/1078-0432.CCR-22-1321","article-title":"Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors","volume":"28","author":"Solomon","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0140","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","article-title":"Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS","volume":"12","author":"Rose Brannon","year":"2021","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.lungcan.2024.107897_b0145","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.18632\/oncotarget.28092","article-title":"Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization","volume":"12","author":"Schmitt","year":"2021","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107897_b0150","article-title":"Detection of MET gene copy number in cancer samples using the droplet digital PCR method","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107897_b0155","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/01.JTO.0000268675.02744.b0","article-title":"The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib","volume":"2","author":"Buckingham","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2024.107897_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00059","article-title":"Prospective feasibility study for using cell-free circulating tumor DNA\u2013guided therapy in refractory metastatic solid cancers: an interim analysis","volume":"1","author":"Kim","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107897_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2018.4305","article-title":"Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer","volume":"5","author":"Aggarwal","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2024.107897_b0170","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241229435","article-title":"Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study","volume":"16","author":"Su","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.lungcan.2024.107897_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.10.334","article-title":"305MO SCC244 plus osimertinib in patients with stage IIIB\/IIIC or IV, EGFR TKI resistant EGFR-mutant NSCLC harboring MET amplification","volume":"33","author":"Yu","year":"2022","journal-title":"Ann. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:18:38Z","timestamp":1723573118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224004318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"alternative-id":["S0169500224004318"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107897","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107897"}}